Surgery Partners (NASDAQ: SGRY) executive Harrison Bane to resign

Rhea-AI Filing Summary

Surgery Partners, Inc. reported that Harrison R. Bane, its National Group President, has decided to resign from his current role, effective October 3, 2025. The company states that Mr. Bane’s resignation is not due to any disagreement with Surgery Partners on operations, policies, or practices, indicating this is a personal or career decision rather than a dispute with the company.

Insights

Corporate governance analyst

Senior executive resigns from key operating role, disclosed as non‑contentious.

Surgery Partners, Inc. disclosed that National Group President Harrison R. Bane will resign effective October 3, 2025. The company explicitly notes that his departure is not the result of any disagreement about operations, policies, or practices, which frames the change as non-adversarial.

A National Group President typically oversees significant parts of day-to-day operations, so a transition in this role can affect continuity and execution until a successor or revised structure is in place. However, the absence of stated disputes reduces concern about immediate strategic upheaval.

The disclosure does not describe succession plans or organizational changes tied to this resignation, so future company communications and filings may clarify how responsibilities are redistributed after October 3, 2025. Overall, the event appears neutral from a governance standpoint based on the information provided.

8-K Event Classification

Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers

1 item

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

Understanding 8-K Material Events →

0001638833FALSE00016388332025-09-112025-09-11

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 11, 2025

Surgery Partners, Inc.

(Exact Name of Registrant as Specified in Charter)

Delaware			001-37576			47-3620923
(State or Other Jurisdiction of Incorporation)			(Commission File Number)			(IRS Employer Identification No.)

340 Seven Springs Way, Suite 600

Brentwood, Tennessee 37027

(Address of Principal Executive Offices) (Zip Code)

(615) 234-5900

(Registrant’s Telephone Number, Including Area Code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.01 per share

SGRY

The Nasdaq Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On September 11, 2025, Harrison R. Bane, National Group President, notified the Board of Directors of Surgery Partners, Inc. (the “Company”) of his decision to resign from his current role effective October 3, 2025. Mr. Bane’s resignation was not a result of any disagreement between the Company and Mr. Bane on any matter related to the operations, policies, or practices of the Company.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

SURGERY PARTNERS, INC.
By:			/s/ David T. Doherty David T. Doherty Executive Vice President, Chief Financial Officer

Date: September 16, 2025

FAQ

Which executive is leaving Surgery Partners (SGRY) and what is his role?

Harrison R. Bane, who serves as National Group President of Surgery Partners, Inc., has decided to resign from his current role.

When will Harrison R. Bane’s resignation at Surgery Partners (SGRY) become effective?

Harrison R. Bane’s resignation from his role as National Group President will be effective October 3, 2025.

Did Harrison R. Bane resign from Surgery Partners (SGRY) because of a disagreement with the company?

The company states that Mr. Bane’s resignation was not a result of any disagreement regarding its operations, policies, or practices.

What SEC item does this Surgery Partners (SGRY) filing relate to?

The disclosure is made under Item 5.02, which covers departures of directors or certain officers, elections of directors, appointments of certain officers, and compensatory arrangements.

Who signed the Surgery Partners (SGRY) report announcing the executive resignation?

The report was signed on behalf of Surgery Partners, Inc. by David T. Doherty, Executive Vice President and Chief Financial Officer.